Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature.
Saved in:
| Title: | Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature. |
|---|---|
| Authors: | Scarborough JA; Systems Biology and Bioinformatics Department, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Eschrich SA; Biostatistics and Bioinformatics Program, Moffitt Cancer Center, Tampa, FL, USA., Torres-Roca J; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA., Dhawan A; Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. dhawana@ccf.org., Scott JG; Systems Biology and Bioinformatics Department, School of Medicine, Case Western Reserve University, Cleveland, OH, USA. scottj10@ccf.org.; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. scottj10@ccf.org.; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. scottj10@ccf.org. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2023 Apr 19; Vol. 7 (1), pp. 38. Date of Electronic Publication: 2023 Apr 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-023-00375-y |
